Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,181.3
1.9 (0.06%)

 

  • STI Straits Times Index
    3,181.3
    1.9 (0.06%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,602.9
    4.6 (0.29%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    28,712.5
    -188.3 (-0.65%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,390.1
    -26.6 (-0.78%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    29,681.0
    60.0 (0.20%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,061.2
    10.9 (0.18%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 383.7M
  • Value: 298.4M
  • Rise: 116
  • Fall: 97
  • Unch: 557

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
CWX Global0.004-0.001
Sembcorp Marine0.200+0.003
P5 Capital0.039+0.001
Jiutian Chemical0.099-0.002
Adventus0.017+0.001
Rex Intl0.183-
Oceanus^0.041-0.001
MM2 Asia0.058-0.001
Genting Sing0.900-0.005
Anchor Resources0.031-

World Indices

World Indices
Name Last Change
Nasdaq 13,857.8 -138.3
HSI 28,665.4 -235.5
HSCEI 10,863.4 -135.9
Jakarta 6,039.5 -10.8
Nikkei 225 29,660.2 +39.2
SSE Comp 3,380.3 -36.5
Shanghai A 3,543.0 -38.2
Shanghai B 245.3 -0.7
KOSPI 3,191.4 +9.0

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

C4 THERAPEUTICS INC C4 THERAPEUTICS INC
Updated on 14 Apr 2021 (End of trading day)
Last (USD): 33.180 Change: +1.600 High: 34.000 Remarks: -
Change (%): +5.07 Low: 31.477
Open 32.370 Yesterday's Close 31.58
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 652,912 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -1.53840 Trailing EPS (USD) e -1.53840 NAV (USD) b 6.5119
PE a - Trailing PE f - Price / NAV b 5.0953
Dividend (USD) d - Cash In Hand (USD) g 4.2145 Issued & Paid-up Shares c 43,119,400
Dividend Yield (%) d - Price / Cash In Hand g 7.873 Treasury Shares h -
Market Cap (M) 1,430.702 Enterprise Value (M) 1,081.933
Piotroski F Score 3 Exchange Code CCCC Par Value ( $ ) n.a.
52 Weeks Volatility (%) n.a. Free Float (%) 76.3
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 12 Mar 2021.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 30 Sep 2020.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference C4 THERAPEUTICS INC NASDAQ 1,430.702 - - 5.0953 -
Industry Biotechnology NASDAQ 2,889.243 106.306 106.381 6.6771 0.613
Local Peer AMGEN INC NASDAQ 143,731.695 19.787 19.787 15.2760 2.575
Local Peer GILEAD SCIENCES INC NASDAQ 82,055.980 667.143 667.122 4.5081 4.157
Local Peer MODERNA INC NASDAQ 64,040.805 - - 25.0023 -
Local Peer ILLUMINA INC NASDAQ 58,078.413 88.534 88.534 12.3729 -
Local Peer VERTEX PHARMACEUTICAL NASDAQ 56,197.804 20.725 20.725 6.4693 -
Local Peer REGENERON PHARMACEUTICALS INC NASDAQ 51,547.619 14.673 14.673 4.6754 -
Local Peer BIOGEN INC NASDAQ 40,016.013 10.003 10.003 3.7397 -
Local Peer ALEXION PHARMACEUTICAL INC NASDAQ 34,306.822 56.856 56.856 2.9445 -
Local Peer BIONTECH SE SPON ADS EACH REP 1 ORD SHS NASDAQ 32,025.685 1,848.599 1,848.489 19.0797 -
Local Peer BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS NASDAQ 27,569.966 - - 7.1254 -
Local Peer SEAGEN INC NASDAQ 26,144.325 42.603 42.603 7.4953 -
Local Peer EXACT SCIENCES CORP NASDAQ 21,498.484 - - 7.6142 -
Other Local Peers 10X GENOMICS INC (NASDAQ), INCYTE CORPORATION (NASDAQ), BIO-TECHNE CORP (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), NOVAVAX INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), BIOMARIN PHARMACEUTICAL (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), BRIDGEBIO PHARMA INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), ABCELLERA BIOLOGICS INC (NASDAQ), ACCELERON PHARMA (NASDAQ), FATE THERAPEUTICS (NASDAQ), EXELIXIS INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), BEAM THERAPEUTICS INC (NASDAQ), OLINK HLDG AB SPON ADS EACH REP 1 ORD SHS (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), SANA BIOTECHNOLOGY INC (NASDAQ), ABCAM PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), VERACYTE INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), SEER INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), INSMED INC (NASDAQ), ALKERMES PLC (NASDAQ), ARVINAS INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), RELAY THERAPEUTICS INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), ORGANOGENESIS HOLDINGS INC (NASDAQ), INSTIL BIO INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), XENCOR INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), BIONANO GENOMICS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), ZENTALIS PHARMACEUTICALS INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), FIBROGEN INC (NASDAQ), MACROGENICS INC (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), CYTOKINETICS INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), PURETECH HEALTH PLC SPON ADS EACH REP 10 ORD SHS (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), UNIQURE N.V. (NASDAQ), BIOATLA INC (NASDAQ), ALLOVIR INC (NASDAQ), APPLIED MOLECULAR TRANSPORT INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), IMMUNOVANT INC (NASDAQ), TRAVERE THERAPEUTICS INC (NASDAQ), PRELUDE THERAPEUTICS INC (NASDAQ), REGENXBIO INC (NASDAQ), PRECIGEN INC (NASDAQ), IMMUNOGEN INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), ALECTOR INC (NASDAQ), KYMERA THERAPEUTICS INC (NASDAQ), MIMEDX GROUP INC (NASDAQ), EDGEWISE THERAPEUTICS INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), IMMUNOCORE HLDGS PLC SPON ADS EACH REP ONE ORD SHS (NASDAQ), SHATTUCK LABS INC (NASDAQ), COMPASS PATHWAYS PLC UNSPON ADS REP 1 ORD SHS (NASDAQ), TRANSLATE BIO INC (NASDAQ), OCUGEN INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), NKARTA INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), AFFIMED N V (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), OMEROS CORP (NASDAQ), VOR BIOPHARMA INC (NASDAQ), PLIANT THERAPEUTICS INC (NASDAQ), CORTEXYME INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), CURIS INC (NASDAQ), MANNKIND CORPORATION (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), PERSONALIS INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), VAXCYTE INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), 4D MOLECULAR THERAPEUTICS INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), GRACELL BIOTECHNOLOGIES INC SPON ADS EACH REP 5 ORD SHS (NASDAQ), VANDA PHARMACE INC (NASDAQ), HUMANIGEN INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), TAYSHA GENE THERAPIES INC (NASDAQ), ITEOS THERAPEUTICS INC (NASDAQ), DYNE THERAPEUTICS INC (NASDAQ), MERUS B V (NASDAQ), PASSAGE BIO INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), INHIBRX INC (NASDAQ), EPIZYME INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC SPON ADS EACH REP 6 ORD SHS (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), AVIDITY BIOSCIENCES INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), COMPUGEN (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), CHIMERIX INC (NASDAQ), IMMATICS N V (NASDAQ), ARDELYX INC (NASDAQ), ASPIRA WOMENS HEALTH INC (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), VAXART INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), ATHIRA PHARMA INC (NASDAQ), KADMON HLDGS INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), SIGILON THERAPEUTICS INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), IKENA ONCOLOGY INC (NASDAQ), AGENUS INC (NASDAQ), POSEIDA THERAPETUICS INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), INVENTIVA SA SPON ADS EACH REP 1 ORD SHS (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), IVERIC BIO INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), NEOLEUKIN THERAPEUTICS INC (NASDAQ), XBIOTECH INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), AKOUOS INC (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), ALTIMMUNE INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), FORTE BIOSCIENCES INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), GREENWICH LIFESCIENCES INC (NASDAQ), VERASTEM INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), GERON CORP (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), FOGHORN THERAPEUTICS INC (NASDAQ), TERNS PHARMACEUTICALS INC (NASDAQ), SUMMIT THERAPEUTICS INC (NASDAQ), AVROBIO INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), SENSEI BIOTHERAPEUTICS INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), FREELINE THERAPEUTICS HLDGS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), OPTHEA LIMITED SPON ADS EACH REPR 8 ORD SHS (NASDAQ), ATRECA INC (NASDAQ), LANDOS BIOPHARMA INC (NASDAQ), XOMA CORP (NASDAQ), CHEMOMAB THERAPEUTICS LTD SPON ADS EACH REP 20 ORD SHS (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), LAVA THERAPEUTICS NV (NASDAQ), ADICET BIO INC (NASDAQ), SESEN BIO INC (NASDAQ), SPRUCE BIOSCIENCES INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), ATHERSYS INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), ONCORUS INC (NASDAQ), AEGLEA BIOTHERAPEUTICS INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), PORTAGE BIOTECH INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), BELLUS HEALTH INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), COGENT BIOSCIENCES INC (NASDAQ), IMMUNOME INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), VIRACTA THERAPEUTICS INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), TREVENA INC (NASDAQ), 9 METERS BIOPHARMA INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), KAMADA LTD (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), CABALETTA BIO INC (NASDAQ), NEXTCURE INC (NASDAQ), DECIBEL THERAPEUTICS INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), IMMUNOPRECISE ANTIBODIES LTD (NASDAQ), MEDICINOVA INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), MEDICENNA THERAPEUTICS CORP (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), LARIMAR THERAPEUTICS INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), SAVARA INC (NASDAQ), BIOVIE INC (NASDAQ), EQUILLIUM INC (NASDAQ), IMV INC (NASDAQ), EVOGENE LTD (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), AXCELLA HEALTH INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), INMUNE BIO INC (NASDAQ), CHIASMA INC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), CHECKMATE PHARMACEUTICALS INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), CONTRAFECT CORP (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), GAIN THERAPEUTICS INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), SIO GENE THERAPIES INC (NASDAQ), ENOCHIAN BIOSCIENCES INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), LONGEVERON INC (NASDAQ), AZIYO BIOLOGICS INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), SYNLOGIC INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), ORGENESIS INC (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), EVAXION BIOTECH AS SPON ADS EACH REP 1 ORD SHS (NASDAQ), METACRINE INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), OTONOMY INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), VIRIDIAN THERAPEUTICS INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), ARAVIVE INC (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), MINERVA NEUROSCIENCES INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), INFLARX N V (NASDAQ), CELYAD ONCOLOGY SPON ADS EACH REPR 1 ORD SHS (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), LUMOS PHARMA INC (NASDAQ), RECRO PHARMA INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), AIKIDO PHARMA INC (NASDAQ), NEUROBO PHARMACEUTICALS INC (NASDAQ), ADVAXIS INC (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), COHBAR INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), VACCINEX INC (NASDAQ), KIROMIC BIOPHARMA INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), BIOCARDIA INC (NASDAQ), MONOPAR THERAPEUTICS INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), WINDTREE THERAPEUTICS INC (NASDAQ), ATYR PHARMA INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), SOLIGENIX INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), CYCLACEL PHARMACEUTICALS INC (NASDAQ), APPLIED DNA SCIENCES INC (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), ANPAC BIO MEDICAL SCIENCE CO LTD SPON ADS EACH REPR 1 ORD SHS CLASS A (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), CYCLO THERAPEUTICS INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), ADITX THERAPEUTICS INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), LIXTE BIOTECHNOLOGY HOLDINGS INC (NASDAQ), HISTOGEN INC (NASDAQ), SONNET BIOTHERAPEUTICS HLDGS INC (NASDAQ), GEOVAX LABS INC (NASDAQ), PRECIPIO INC (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), INMED PHARMACEUTICALS INC (NASDAQ), SENECA BIOPHARMA INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 5 ORD SHS(R/S) (NASDAQ), BENITEC BIOPHARMA INC (NASDAQ), BRIACELL THERAPEUTICS CORP (NASDAQ), SENESTECH INC (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ)
Global Peer CSL LTD ASX 121,881.136 38.861 32.025 11.5338 1.096
Global Peer WUXI BIO HKEx 437,643.337 230.605 230.607 17.9494 -
Global Peer BEIGENE HKEx 214,104.752 - - 7.1365 -
Global Peer SINO BIOPHARM HKEx 150,886.941 48.456 48.457 7.5990 -
Global Peer ZAI LAB-SB HKEx 112,230.855 - - 12.3781 -
Global Peer JOINN HKEx 35,612.909 100.607 100.607 24.5217 0.250
Global Peer Lonza SGX 5,940.891 4.560 4.560 0.5844 5.624
Global Peer EMERGENT BIOSOLUTIONS INC NYSE 3,989.872 13.077 13.077 2.7573 -
Global Peer GENSCRIPT BIO HKEx 29,578.663 - - 4.2305 -
Global Peer NUVATION BIO INC NYSE 2,518.211 - - 17.7074 -
Other Global Peers ARCUS BIOSCIENCES INC (NYSE), 3SBIO (HKEx), VIVA BIOTECH (HKEx), JACOBIO-B (HKEx), JW THERAP-B (HKEx), KINTOR PHARMA-B (HKEx), MYOVANT SCIENCES LTD (NYSE), POLYNOVO LIMITED (ASX), HAOHAI BIOTEC (HKEx), ALPHAMAB-B (HKEx), FRONTAGE (HKEx), MESOBLAST LTD (ASX), ASCENTAGE-B (HKEx), JHBP-B (HKEx), TELIX PHARMACEUTIC (ASX), IMUGENE LIMITED (ASX), ACTINIUM PHARMACEUTICALS INC (NYSE American), SINOMAB BIO-B (HKEx), DPHARMA (Bursa), LEE'S PHARM (HKEx), ANTEOTECH LIMITED (ASX), OPTHEA LIMITED (ASX), ESSEX BIO-TECH (HKEx), ASCLETIS-B (HKEx), LINEAGE CELL THERAPEUTICS INC (NYSE American), SQZ BIOTECHNOLOGIES CO (NYSE), 22ND CENTURY GROUP INC (NYSE American), NANOVIRICIDES INC (NYSE American), IMMUTEP LTD (ASX), NEXT SCIENCE LTD (ASX), KAZIA THERAPEUTICS LIMITED (ASX), ENZO BIOCHEM INC (NYSE), BIOMX INC (NYSE American), CEL-SCI CORP (NYSE American), BIONOMICS LTD (ASX), IBIO INC (NYSE American), NEUREN PHARMACEUTICALS LTD (ASX), ARMATA PHARMACEUTICALS INC (NYSE American), AIM IMMUNOTECH INC (NYSE American), PALATIN TECHNOLOGIES INC (NYSE American), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), LEAF RESOURCES LTD (ASX), SYNTHETIC BIOLOGICS INC (NYSE American), CHIMERIC THERAPEUTICS LTD (ASX), GENETIC TECHNOLOGIES (ASX), CYNATA THERAPEUTICS LTD (ASX), REGENT PACIFIC (HKEx), ACTINOGEN MEDICAL LTD (ASX), PRESCIENT THERAPEUTICS LIMITED (ASX), ALTERITY THERAPEUTICS LIMITED (ASX), INDIA GLOBALIZATION CAPITAL INC (NYSE American), INVEX THERAPEUTICS LTD NPV (ASX), MEMPHASYS LTD (ASX), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), PATRYS LIMITED (ASX), ORAGENICS INC (NYSE American), Suntar Eco-City (SGX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), BIOTRON (ASX), ADALTA LTD (ASX), AVECHO BIOTECHNOLOGY LTD (ASX), REGENEUS LTD (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), AUSTRALIAN PRIMARY HEMP LTD (ASX), RHINOMED LIMITED (ASX), AMPLIA THERAPEUTICS LTD (ASX), CONSTELLATION TECHNOLOGIES LTD (ASX), HOLISTA COLLTECH LIMITED (ASX), NOVABAY PHARMACEUTICALS INC (NYSE American), CRYOSITE (ASX), NANOLLOSE LTD (ASX), ANATARA LIFESCIENCES LTD (ASX), LIVING CELL TECHNOLOGIES (ASX), FACTOR THERAPEUTICS LIMITED (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --2.990
-8.27 %
10 Days --3.810
-10.30 %
20 Days --10.550
-24.13 %
Medium Term Return 3 Months --6.370
-16.11 %
6 Months -+9.040
+37.45 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 22.400 - 48.975 Change From 1 Year Low +10.780 % Change From 1 Year Low (%) +48.12
Change From 1 Year High -15.795 % Change From 1 Year High (%) -32.25
2 Years Range 22.400 - 48.975 Change From 2 Years Low +10.780 % Change From 2 Years Low (%) +48.12
Change From 2 Years High -15.795 % Change From 2 Years High (%) -32.25
5 Years Range 22.400 - 48.975 Change From 5 Years Low +10.780 % Change From 5 Years Low (%) +48.12
Change From 5 Years High -15.795 % Change From 5 Years High (%) -32.25
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

C4 Therapeutics, Inc. provides new class of targeted protein degradation. It develops Degronimid platform that incorporates small molecule binders to target disease-causing proteins and facilitate their destruction and clearance from the cell through the natural ubiquitin and proteasome system. The company was founded by James E. Bradner, Kenneth C. Anderson, Nathanael S. Gray and Marc A. Cohen in October 2015 and is headquartered in Cambridge, MA.

Historical Price Data

Date Open High Low Close Volume VWAP
14 Apr 2021 32.370 34.000 31.477 33.180 652,912 -
13 Apr 2021 30.560 32.040 29.750 31.580 673,227 -
12 Apr 2021 32.600 32.990 30.330 30.710 513,303 -
09 Apr 2021 33.540 33.780 32.000 32.660 654,544 -
08 Apr 2021 36.610 36.610 33.380 33.720 448,407 -
07 Apr 2021 36.755 38.370 35.815 36.170 304,957 -
06 Apr 2021 37.450 38.460 36.430 37.490 1,071,534 -
05 Apr 2021 38.320 38.750 36.300 37.510 377,702 -
01 Apr 2021 36.800 39.150 36.260 38.630 295,807 -
31 Mar 2021 33.000 38.400 32.720 36.990 517,035 -
30 Mar 2021 33.030 33.880 31.500 32.900 211,486 -
29 Mar 2021 36.980 36.980 32.510 33.320 266,409 -
26 Mar 2021 39.950 40.560 36.515 37.320 585,387 -
25 Mar 2021 36.550 40.120 36.010 39.780 237,300 -
24 Mar 2021 38.290 38.490 37.070 37.860 358,607 -
23 Mar 2021 40.270 40.800 38.000 38.100 337,204 -
22 Mar 2021 39.030 41.255 38.800 40.330 253,843 -
19 Mar 2021 39.560 42.230 34.000 38.750 1,699,425 -
18 Mar 2021 43.470 43.470 39.200 40.010 282,562 -
17 Mar 2021 43.470 44.920 42.831 43.730 161,117 -
16 Mar 2021 44.240 45.760 43.050 43.660 184,727 -
15 Mar 2021 44.890 45.941 43.000 44.250 155,117 -
Summary
Current 2 Weeks
(31 Mar 2021 to 14 Apr 2021)
33.000 39.150 29.750 33.180 5,509,428 -
Previous 2 Weeks
(17 Mar 2021 to 30 Mar 2021)
43.470 44.920 29.750 32.900 4,393,340 -
4 Weeks from
(17 Feb 2021 to 16 Mar 2021)
41.010 42.000 29.750 43.660 4,006,780 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.